JP Morgan Upgrades Imax to Overweight, Raises Price Target to $47

Benzinga · 3d ago
JP Morgan analyst David Karnovsky upgrades Imax (NYSE:IMAX) from Neutral to Overweight and raises the price target from $32 to $47.